Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

Rhea-AI Summary

Altimmune, Inc. (Nasdaq: ALT) will announce its second quarter 2021 financial results on August 11, 2021. Management will host a conference call at 8:30 am E.T. to discuss the results and provide further business updates. The conference can be accessed via dial-in or webcast. Altimmune is focused on developing treatments for obesity and liver diseases, with a pipeline that includes therapies for NASH and chronic hepatitis B.

Positive

• Upcoming conference call to discuss financial results may attract investor interest.
• Focus on treatments for obesity and liver diseases indicates potential for growth in an important healthcare sector.

Negative

• None.

GAITHERSBURG, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 11, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the second quarter 2021 financial results and provide a business update.

Conference Call Information:

Date:	Wednesday, August 11
Time:	8:30 am Eastern Time
Domestic Dial-in:	(844) 615-6509
International Dial-in:	(918) 922-3148
Conference ID:	9484516
Webcast:	https://edge.media-server.com/mmc/p/ne5cqqtf

About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor and Media Contact:
Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com

FAQ

When will Altimmune report its second quarter 2021 financial results?

Altimmune will report its second quarter 2021 financial results on August 11, 2021.

What time is Altimmune's conference call for Q2 2021 results?

The conference call will take place at 8:30 am E.T. on August 11, 2021.

How can investors access Altimmune's conference call?

Investors can access the conference call via dial-in or by using the provided webcast link.

What is Altimmune's focus in biopharmaceutical development?

Altimmune focuses on developing treatments for obesity and liver diseases.

What are some products in Altimmune's pipeline?

Altimmune's pipeline includes therapies for NASH and chronic hepatitis B.